























































Research Question: How can an academic medical center best implement a 
bundled payment model? 
 
Importance: Centers for Medicare & Medicaid Services are requiring health care 
systems to employ mandatory bundled payment reimbursement structures, and they 
need guidance on how best to implement them. 
 
Specific Aims: To assess UNC Health Care’s experience with integrating and 
implementing episodic bundled payments. 
 
Methods: Triangulation of in-depth interviews with key stakeholders at UNC Health 
Care, Enterprise Analytics & Data Sciences (EADS), and Blue Cross and Blue Shield 
of North Carolina with reports of successful implementation strategies from other 
institutions derived from a systematic review of the literature. 
 
Results: The implementation of an alternative payment method, such as an episodic 
bundled payment, requires buy-in, constant communication, and early collaboration 
with key stakeholders. Stakeholders from differing industries also had differing 
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 In 2010, the Patient Protection and Affordable Care Act (ACA) was signed into 
law by President Barack Obama. One of the key goals of this legislation was to overhaul 
how health care is delivered in the United States. The Center for Medicare and 
Medicaid Innovation (CMMI) was created by the ACA as a new office within the Centers 
for Medicare and Medicaid Services (CMS). This new unit in CMS was tasked with the 
goal of developing and testing new payment delivery models, while also maintaining or 
amplifying the quality of care provided to patients in Medicare, Medicaid, and Children’s 
Health Insurance Program as it also attempted to bring down the costs of the program1. 
To attempt to achieve these provisions, CMMI began experimenting with alternative 
payment models, one of which is the episodic bundled payment. 
 
Background and Significance 
 For years, CMS has been faced with exponentially rising medical costs and 
enrollment. Total enrollment in Medicare has grown from 45,472,051 in 2008 to 
52,506,598 in 2013, with about a 10% growth in between each year during that time 
period2. In addition, the Kaiser Family Foundation projected that the total spending of 
Medicare will grow from $591 billion in 2016 to nearly $1.1 trillion by 2026 if current 
trends continue3. This will lead to a dramatic increase in the already large percentage of 
the United States GDP that is dedicated to health care and specifically to Medicare. In 





reimbursing health care, and one of these avenues includes alternative payment 
models. 
 Before the passing of the ACA, the large majority of health care reimbursement 
in the United States was fee-for-service. This means that when a health care provider 
records a diagnosis, orders a test, performs a procedure, or delivers virtually any other 
service, each portion of the encounter is billed separately4. This method of 
reimbursement, making health services essentially pieces of work, incentivizes frivolous 
test and/or procedure ordering, and can even dissuade physicians from performing the 
most evidence-based, effective therapy because that could lead to lower levels of 
billable services. Therefore, as part of its renewed mission to curb costs and increase 
the quality of care that it reimburses, CMS set several goals at the beginning of 2015; 
one of which included expanding the amount of Medicare reimbursement through 
alternative payment models to >50% by the end of 20185. Examples of these alternative 
payment models include: Accountable Care Organizations (ACOs), Medicare Shared 
Savings Program (MSSP), and a few different bundled payment models6. The idea 
behind a bundled payment is that instead of billing for each aspect of care individually, 
the payor instead defines an episode from start to end, and provides a single, all-
inclusive payment for it. For example, a surgical procedure bundle could begin at the 
start of the operation and end 90-days post-op. CMS would then reimburse a set dollar 
amount for the entire care, including all health services, of that patient for that episode7. 
In the example of a surgical procedure, this would result in the surgeon’s fee, physical 





and all other services needing to be adjudicated based on the lump payment set by 
CMS. This can be a point of dispute, as the hospital and physicians need to negotiate 
the rates and where the funds flow will be appropriated in advance. Additionally, CMS 
hypothesized that this would lead to an improvement in patient care, because any 
complications resulting from the episode would not be reimbursed by CMS, so the 
providers, hospitals, and other service providers would need to go the extra mile to 
provide quality care in order to avoid losing money on the procedure. 
 One of the more compelling arguments in favor of utilizing bundled payments 
came in the 2016 Harvard Business Review article “How to Pay for Health Care” by 
Michael Porter and Robert Kaplan8. The duo described the flaws of a fee-for-service 
and then compared bundled payments to a capitation system and explained why 
bundled payments provide higher value care. They were able to synthesize a 
compelling argument for why bundled payments are the superior reimbursement 
method. Within this argument, they included five criteria which must be met when 
creating a bundle to maximize value. These included: the payment must cover the 
overall care required to treat the condition, the payment must be contingent on 
delivering good outcomes that matter to the patient, the payment must be adjusted for 
risk, the payment must provide a fair profit for effective and efficient care, and the 
providers must not be held accountable for unrelated care or catastrophic cases8. They 
added three ways that bundled payments can improve health care that capitation is 
unable to: bundled payments require integrated, multidisciplinary care, bundled 





and they predict that bundled payments lead to cost reduction, even suggesting savings 
of 20-30% for some conditiions8. Finally, they brought to light several challenges that 
would need to be accounted for in the process of creating a bundled payment model. 
They noted that the most difficult parts of creating a bundled payment would involve: 
defining a condition, defining an episode length, and assessing risk8. 
The bundled payment of particular interest to this project is the Comprehensive 
Care for Joint Replacement (CJR) Model. The CJR model was the first episodic bundled 
payments model CMS devised after the passing of the ACA. The rationale for choosing 
CJR is simply because it represents the most common inpatient surgical procedure 
CMS reimburses, with >400,000 hip or knee joint replacements in 2014 totaling more 
than $7 billion in CMS payments to providers9. The frequency of the procedure is an 
important determinant in choosing an “episode” to be bundled, since bundling requires 
data from a high volume of procedures in order to standardize them. An important 
contributor to CMS’s decision to create the CJR bundle was the large range of 
reimbursement rates in different regions of the country. CMS noted that in some less 
affluent areas, patients undergoing CJR experienced as high as three times the average 
post-operative complication rate9. This led to CMS facing a range of expenditure for 
surgery, hospitalization, and recovery for a hip or knee replacement of from $16,500 to 
$33,000 in some areas9. CMS thought that by synthesizing and enacting this CJR 
model as a national innovation it could test whether standardizing commonly done 
procedures would bring down costs and increase quality. In order to create a balanced 





Metropolitan Statistical Areas, or counties which have a core urban area with a 
population >50,0009. The approximately 800 hospitals that were located in them and 
already being paid under the Inpatient Prospective Payment System were required to 
participate in the CJR bundle experiment9. The “episode” associated with the CJR 
bundle begins by defining the beginning of the episode of care as the admission of a 
patient who is ultimately discharged with either Diagnostic Related Group (DRG) codes 
469 or 470; the episode ended at 90 days post-operative9. At the outset, CMS set target 
prices for each unique geographic area with either of the DRGs and each year every 
hospital’s total episode cost was compared with the benchmark that CMS had set9. 
Hospitals would then be able to receive a bonus if they met quality benchmarks and 
stayed below the target price; hospitals might be required to pay money to CMS if they 
went over the target or failed to meet certain quality bench marks. Examples of these 
benchmarks include: 90-day readmission rate and surgical site infection. 
Results thus far have shown some modest successes in some health systems, 
but they have also been met with substantial organizational challenges. For instance, a 
study by Whitcomb et al. of Baystate Health, a health system in Western 
Massachusetts, revealed that patients who underwent hip replacement under a bundled 
payment were more likely to be discharged directly home with in-home rehabilitation 
(87% vs. 63%)10. They noted that cost per case was lower for the bundled patients 
($22,567 vs. $26,412). However, they noted this difference could be exaggerated as it 
was simply the claim amount and does not account for all of the added administration 





attributed to lowering the utilization of Skilled Nursing Inpatient Facilities (SNIFs) and 
discharging more of their patients directly home10. The study of Baystate Health 
illustrates a common criticism: that bundles might not necessarily be saving money 
themselves but, rather, because of heightened self-awareness within the health system, 
areas of potential cost savings are discovered incidentally. 
Since their introduction, the idea of utilizing bundled payments as a health care 
reimbursement method has been met with criticisms. One of the more prominent 
criticisms is the fear that forcing physicians to participate in this bundle and take on 
significant financial risk will cause them to “cherry-pick” patients, refusing to treat 
patients with significant co-morbidities or risk of complications as a way of avoiding 
financial penalty11. A Medscape article asked physicians if they would ever consider 
cherry-picking patients. Most of the respondents said that answering this question would 
require a lot of “what-ifs”, but one Infectious Disease physician remarked, “If my ratings 
and livelihood depended on outcomes, I would probably cherry-pick patients to some 
extent11”. If private practice physicians begin cherry-picking only healthy patients, this 
would leave patients with significant comorbidities or risk of complications with few 
options. Many may simply avoid care, or they may seek care at academic medical 
institutions, many of whom cannot deny care. This led to fear that academic medical 
institutions would be at increased risk. To address this fear, CMS formulated a modified 
methodology. 
The risk of physicians cherry-picking healthy patients within bundled payments 





was published after soliciting feedback from member hospitals, professional 
organizations, and other pertinent stakeholders. One “anti-cherry-picking” method is to 
penalize a hospital only if the episode cost was greater than three standard deviations 
higher than the expected episode price in their geographic area12. Having such a 
generous penalty threshold should greatly lower the risk of hospitals and care providers 
in the absence of some negligence that led to the expense increase12. CMS argued that 
holding member hospitals to this standard was just, so long as hospitals engage in care 
redesign because this would lead to penalties being enforced few and far between12. 
CMS also decided to introduce stop-loss and stop-gain limits for these episodes as an 
added layer of security. This means that there is a theoretical maximum to the savings 
or penalties a hospital would incur, although, this would not protect hospitals that exhibit 
gross negligence in the quality of the care provided12. As of the beginning of 2017, CMS 
has yet to report data on whether or not these interventions are effective12. 
 As an academic medical institution, and quaternary health care provider for the 
people of North Carolina, the UNC Medical Center had unique challenges to overcome 
as it prepared for the implementation of the mandatory bundle from CMS. One of the 
most important challenges unique to UNC’s situation is that it is unable to turn patients 
with significant comorbidities and medical risk away; it could, theoretically, be at risk for 
a higher complication rate than occurs in other institutions. In addition, UNC Medical 
Center is located close to another large academic medical center, Duke University 
Health System, and neither UNC nor Duke can control where their patients go for 





subsequent care can end up seeking care at Duke, which UNC could conceivably have 
to finance out of its bundle. This necessitated extra caution on UNC’s part to insure it 
could adequately monitor the patients for the entire bundle period. Finally, UNC Health 
Care only has two joint replacement surgeons on faculty, while some other similarly 
sized institutions may have as many as five19. This led to concern that they might not be 
able to reach the high volume necessary in a bundled payment system to maximize its 
risk-adjusted return13. How has UNC met those challenges? The remainder of this 
paper addresses that question. 
 
Methods 
 UNC Health Care’s experience with episodic bundled payments thus far is limited 
to the mandatory CJR bundle employed by CMS. The goal of this study is to assess the 
effectiveness of UNC Health Care’s implementation of the CJR bundle. This project 
attempts to evaluate and characterize UNC Health Care’s involvement with this bundled 
payment by triangulating in-depth interviews with key stakeholders at UNC Health Care, 
Enterprise Analytics and Data Sciences (EADS), and Blue Cross and Blue Shield of 
North Carolina with reports of other institutions’ implementation strategies.  
 The mandatory CJR bundle began to be planned for at UNC Health Care in 
2015. In the time leading up to its implementation, Dr. Alan Stiles, Senior Vice President 
for Strategic Initiatives at UNC Health Care, was put in charge of overseeing its 
execution. Dr. Stiles created a committee that worked to assess what changes in care 





 I started the study by collecting information about other institutions’ experiences 
with episodic bundled payment programs through a limited systematic review of the 
literature (Appendix 1). I then sought interviews with 14 individuals whom I identified as 
key stakeholders in the process of implementing the CJR model at UNC Health Care. 
Several of those whom I identified as key stakeholders informed me that they would not 
be the most effective person to interview, and directed me elsewhere. I conducted 
interviews with seven individuals during June 2017 using the attached interview protocol 
(Appendix 2). Before beginning each interview, each participant was given the option to 
remain anonymous. This project was deemed “not human subjects research” by the 
UNC IRB (study #: 17-1232). A full list of the seven individuals with whom I conducted 
interviews, along with their credentials, can be found in Appendix 3. Finally, I was the 
sole coder and analyst of the responses; the coding scheme can be seen in Appendix 4. 
 
Findings and Discussion 
The conclusions from the limited systematic review of the literature, synthesized 
with the results of interviews with 7 key stakeholders, make it clear that the 
implementation of an alternative payment model such as an episodic bundled payment 
produces many challenges and equivocal results. The institutions whose experiences 
were encountered in the limited systematic review (Appendix 1) showed some modest 
successes and many challenges. In addition, all of the key stakeholders who were 
asked about UNC Health Care’s experience with bundled payments so far said it was 





noted that the process of integrating the CJR model was useful because it forced UNC 
to truly analyze the steps taken to deliver this health service and stakeholders noticed 
what, specifically, was driving costs up. Another respondent said, “We had gotten into 
the habit of sending all of our patients to this very plush rehab setting in Siler City and 
that might [have been] contributing to higher costs14.”  
CMS used evidence-based data when designing the CJR bundle and deciding 
that it would involve mandatory enrollment. For instance, when reading through their 
justification for deciding to use the model, there were several benefits that were pointed 
out in the Harvard Business Review article by Michael Porter and Robert Kaplan8. CMS 
pointed out the fact that beneficiaries would be able to retain the freedom of choice for 
services and providers9, similar one of the key benefits to bundled payments pointed out 
by Porter and Kaplan, that bundled payments would actually encourage competition8. In 
addition, the idea for CMS to endorse bundled payments over other reimbursement 
strategies, such as capitation, is justified based on all of the arguments that Porter and 
Kaplan pointed out in their article8. 
 Some of the articles included in the systematic review explained modest success 
with the CJR model in bringing down episode costs slightly or reducing the length of 
stay in the primary hospitalization, but the authors also expressed doubt about the 
cause of this success being the implementation of the bundles. For example, Courtney 
and colleagues analyzed the differences between 125 total joint replacement patients 
under the CJR model and 91 total joint replacements from the year before 





reimbursement of $17,754 for the bundled patients and $18,316 for the non-bundled 
patients20. They noted no difference in total episode costs to CMS between the bundled 
and non-bundled patients ($38,107 vs. $37,851). They did note a slight fall in the mean 
length of stay in the bundled patients (4.02 days vs. 5.27 days), but no statistically 
significant difference in the 90-day readmission rate (10% vs. 18%, p=0.083)20. This is, 
however, a clinically significant outcome, as 8% of patients were not being readmitted to 
the hospital with a complication. They also noted that their hospital experienced 
challenges in adapting for the data collection necessary to bundled payment 
implementations, and in being forced to include their medically complicated patients in 
the bundle. They conclude that tertiary-care hospitals will face the biggest risk with the 
mandatory bundles, as they will likely treat more medically complex patients, and even 
a few high-cost outliers can severely reduce the hospital’s profit margin on bundling20. 
When I asked them to describe what specific steps UNC Health Care had taken 
to prepare for bundled payment implementation, the respondents gave a variety of 
responses. The most common response was attempting to standardize care, mentioned 
in 42.9% of the interviews. The next most common response was the early engagement 
of affected physicians, which 28.6% of respondents noted. Specifically, Carol Lewis 
suggested that among several important issues to consider for the affected physicians 
are, the clinical workflow and how the bundle would change workflow within the clinic16. 
Finally, utilizing/preparing the electronic medical record, creating a committee dedicated 
to the implementation, and consulting an outside expert, were each mentioned by at 





 I asked respondents how UNC could get the buy-in from physicians, and the 
responses were equivocal. The most common response was to emphasize the 
physicians’ needs, mentioned in 3 out of the 7 interviews. Jeffrey Fuller claimed that 
emphasizing value was the most important strategy to elicit buy-in15. One of each of the 
remaining stakeholders said that employing a team-based approach, employing a 
constant feedback cycle, and working to achieve best practice/protocol would be the 
best strategy. Dr. Kelly also added that education is another important piece for 
obtaining physician buy-in because, “Many of us [physicians] were just trained to deliver 
care. We weren’t trained to prevent episodes of visits and other such things that were 
unnecessary18.” Dr. Mauro provided another significant barrier to be overcome in the 
effort to secure physician buy-in: achieving consensus on standardizing the care plan, 
“even coming to a consensus on what prosthesis to use19”.  
 I asked stakeholders how they think the bundled payment system will alter funds 
flow. Again, there was no consensus on a common answer. Almost half (42.9%) said 
that a bundled payment arrangement would change funds flow a lot, 42.9% said they 
were unsure, and 1 said it wouldn’t change funds flow. Mr. Yount of Blue Cross and 
Blue Shield of North Carolina noted that patients who are involved in a bundled 
payment with a private insurance plan with a high deductible will be seeing the majority 
of the cost upfront, as opposed to seeing their costs spread out over the course of the 
care in a fee-for-service system17. One UNC Health Care leader also noted that a 
difference to consider in a bundled payment arrangement is that there isn’t any 





fee-for-service arrangement, each individual code or service would be sent in, rated, 
and based on a fee schedule that is pre-arranged with the payor19. The fact that 
respondents had no consensus on funds flow reflects the payment model’s complexity 
and UNC’s relatively short experience with it. The lack of consensus may also emerge 
from the lack of independent resources for conducting internal research on UNC’s 
success with the model. 
 Respondents also gave me a number of different reactions when I asked about 
the most prominent barrier to the implementation of bundled payments at UNC Health 
Care. Almost a third of respondents emphasized the intensity additional changes 
needed in care management/coordination. Another 28.6% of them felt that institution 
willingness or the institution being too risk averse was the largest barrier. Finally, 
obtaining engagement with affected parties, systematic issues in the realm of health 
care, or simply is not enough industry drive were emphasized by three other 
respondents. Carol Lewis also added that getting access to data is a large barrier: 
“…data to be able to benchmark how you compare to competitors, because everybody 
can look at their current costs and say they can be lower, but if you’re already in the 
lowest percentile…then you certainly don’t want to start there in terms of trying to get 
improvement16.” Dr. Stiles also noted that, after close consideration of costs, “…the 
most disappointing thing about it was that there really was very little perioperative 
change in expense that we could find to do13.”   
 I asked if other alternative payment models had different or similar, and 83.3% of 





that they had similar barriers added the disclaimer that “it’s hard to compare them18.” All 
of the respondents immediately considered UNC Health Care’s journey to becoming an 
Accountable Care Organization (ACO) as the alternative payment model to compare 
with the episodic bundled payment. For instance, Jeffrey Fuller noted that from a data 
analytics perspective, the ACO is concerned with “…the warning signs of deteriorating 
condition, how do we know we’re not missing those high-risk patients? How can we 
identify them as early as possible15?” Understanding which barriers are unique to which 
kind of payment model is important: if the alternative payment models have completely 
different barriers, then the institutional response to one may be wholly inadequate as a 
response to the other.  
 I asked what other academic institutions can take away from UNC Health Care’s 
experience with implementing bundled payments and, once again, found no consensus. 
Almost a third of respondents said that we don’t know yet or it’s hard to say. One 
respondent said that we may not be the best example. Almost half agreed that early 
partnership/collaboration is the key piece of advice that other academic medical centers 
can take away from UNC Health Care’s experience, even though all noted UNC’s short 
experience to date with the implementation. 
 What is the future of episodic bundled payments at UNC Health Care? More than 
half of the key stakeholders with whom I spoke think that episodic bundled payments do 
play a role in the future of UNC Health Care, but the rest are unsure or don’t see them 
playing a role. Dr. DeWalt noted that UNC Health Care is going to be more focused on 





create our own internal bundles14.” Some of the hesitation right now stems from the 
current political environment as well. Right now, UNC Health Care does not have any 
bundled payments set up with private insurers, so if CMS decides to move away from 
mandatory bundles, that could spell the end of bundled payments at UNC Health Care. 
 I asked if certain procedures or admissions are more amenable to being included 
in a bundled payment arrangement, and 100% of them agreed that they would. Most of 
the respondents mentioned the fact that anything procedural or surgical is much easier 
to standardize, and thus, would be more amenable to bundling. Carol Lewis added that 
surgeries and procedures would be easiest, and additionally, that you need high 
volume, something that is easily standardized, and also that costs are not too affected 
by underlying differences in the population16. Dr. Stiles emphasized that special patient 
considerations need attention as well. For example, CMS has a heart and vascular 
bundle, but the patients who may be eligible for that care plan could be presenting to 
the Emergency Department…not at all like the patient considerations surrounding those 
who electively chose a joint replacement. Since CMS requires the provider to give 
patients considerable information before they are able to be discharged, just 
standardizing and streamlining the process of getting this information to the patient 
present an unexpected challenge13. 
 Finally, I asked the stakeholders whether the implementation of episodic bundled 
payments at UNC Health Care led to an overall increase in the quality of the care 
provided to patients. More than half agreed that it has improved care, but the rest were 





has changed, it has brought a renewed focus to what UNC Health Care is aiming to 
achieve. He argued that it has helped put all of this contemporary data in the hands of 
providers, which they may not have been seeing before13. Dr. Kelly, who said that it 
hasn’t changed quality, feels that it has simply been “…such a small footprint. It hasn’t 
really changed much ay UNC in general18.” 
 In general, the results of the interviews showed that the implementation of an 
alternative payment model such as an episodic bundled payment is a challenging 
undertaking requiring buy-in from many stakeholders. More importantly, there needs to 
be a clear plan in place, with the opportunity for constant feedback. The lack of 
consensus in these interviews drives this point home. Different stakeholders from 
different fields had differing views of barriers, successes, strategies for enhancing buy-
in, and the change this model does – or doesn’t create. 
 The major limitation of the study was the fact that UNC Health Care is still fairly 
early in its experience with episodic bundled payments, so some of the questions asked 
did not receive complete answers from all of the respondents. Another major limitation 
of the study is its reliance on only 7 interviews; only one of those had a payor’s 
perspective in mind. Additionally, the literature on other academic medical centers’ 
experiences with episodic bundled payments is thin, depriving us of context for the UNC 
experience. 
Conclusions 
 As CMS continues to receive feedback and data from the first mandatory bundle, 





payments in the U.S. Health Care system. Academic medical centers have served as a 
great model for the country as a whole, given that they are usually quaternary service 
providers, required to see all patients.  
 At this writing, the future of the ACA is undetermined. However, even if the ACA 
were to be repealed, it is unlikely that many of its key provisions would disappear, 
including payment model innovation. Additionally, the CJR model has already been 
implanted, and even repeal of the ACA would not necessarily touch on CMS’s use of 
this payment model. Future mandatory bundles, specifically the heart and vascular 
bundles, are already being implemented in some areas, and are being planned for and 
analyzed for strategies to best prepare for their implementation in others. In short, the 
pieces are already moving and in place in so many areas, that it is unlikely for the 
system to reverse course. Finally, UNC Health Care will continue to adapt to the ever 
changing environment of the United States Health Care system and serve the people of 
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APPENDIX 1 - Limited Systematic Review  
 
Introduction 
 The passing and implementation of the Patient Protection and Affordable 
Care Act in 2010 led to sweeping changes in the United States Health Care system. 
The ACA called for the creation of a new unit within CMS called the Center for 
Medicare and Medicaid Innovation (CMMI) to help manage and come up with these 
changes, while also attempting to bring down costs for CMS. One of the many 
changes proposed was the goal of having at least 30% of payments financed via 
alternative payment models by 2016 and 50% by 20181. To help accomplish this 
goal, and to provide further research into the future utility of episodic bundled 
payments, CMMI developed the Complete Joint Replacement (CJR) model. The 
model was published in July of 2015, and hospitals who were selected to participate 
were required to begin utilization of the model starting in April of 20152. This put the 
onus directly on health care systems to successfully develop, implement, and report 
their own version of the model.   
Many of the 67 Metropolitan Statistical Area hospitals who were chosen to 
participate in the bundle are academic medical centers. These centers have the 
added challenge of often being quaternary care providers and are typically required 
to see even the sickest patients, which comes with an increased risk. Therefore, 
academic medical centers need to take extra steps to successfully implement this 
model, as they will tend to have a higher number of barriers. To prepare for this, 
UNC Health Care has taken steps to hopefully best prepare itself for this 
implementation, but it would be prudent to examine the literature for strategies that 





This limited systematic review attempted to answer the following questions: 
1.) How have health care systems in the United States handled the 
implementation of bundled payments? 
2.) What challenges have health care systems encountered in the 
implementation of bundled payments? 
3.) What insights can health care systems offer to other health care systems who 
are attempting to implement bundled payments? 
 
Methods 
 A literature review was performed using PubMed through the Health Sciences 
Library at the University of North Carolina at Chapel Hill. The search was performed 
on May 6th, 2017. Specific search criteria were: “bundled payments AND 
implementation AND health system”. This search yielded 17 articles. Relevance was 
determined first by examining the title of the articles and then through analysis of 
their abstracts. Eight of these articles were excluded for the following reasons: some 
of them did not take place or focus on the United States Healthcare system. This is 
integral to inclusion in the systematic review, as we are concerned with experiences 
with implementation in the unique landscape of the U.S. system, and CMS 
mandatory bundles would only be present in the United States. Several of the 
articles did not discuss the implementation of bundled payments, or simply 
referenced bundled payments twice in passing. One of the articles was excluded 
because it only examined the clinical outcome effects on dialysis patients of a bundle 
being implemented, but did not discuss any of the organizational or systemic issues 




after the ACA was passed discussing the theoretical effects of alternative payment 
models on the care of Urological cancer patients. Finally, one more article was 
excluded because it was a preliminary analysis of variables to possibly consider in 
designing a bundled payment, but had nothing to say regarding its implementation. 
The remaining nine articles were reviewed and analyzed for quality using the CASP 
appraisal tool for qualitative research, which is included at the end of this appendix. 
The articles were then rated on a scale of either “poor”, “fair”, or “good”, and the 
results of this rating can be seen in Table 1. Those articles that were deemed not to 
be appropriate to be appraised with the CASP appraisal tool for qualitative research 
were instead critically appraised for their overall quality on the basis for their risk of 
bias, including selection bias, measurement bias, and confounding. These results 
were also included in Table 1. 
Authors Title Year Type Quality 
Courtney PM et al.3 Are Bundled Payments a Viable 
Reimbursement Model for Revision Total 
Joint Arthroplasty? 
2016 Qualitative Good 
Porter ME and Kaplan 
RS.4 
How to Pay for Health Care 2016 Commentary / 
Opinion Piece 
Good 
Randazzo G and Brown 
Z.5 
Transitioning From Volume to Value: A 







Whitcomb WF et al.6 Experience with Designing and 
Implementing a Bundled Payment Program 






George M, Bencic S, 
Bleiberg S, Alawa N, and 
Sanghavi D.7 
Case study: Delivery and  
payment reform in congestive heart failure at 
two large academic centers. 
2014 Case Study Good 
Kamath AF et al.8 Payment in Total Joint Care: Survey of 
AAHKS Membership Attitudes and 




Chambers JD et al.9 What can we learn from the U.S. 
expanded end-stage renal disease bundle? 
2013 Qualitative Good 
Delisle DR10 Big things come in bundled packages: 
implications of bundled payment systems in 
health care reimbursement reform. 
2012 Commentary / 
Opinion Piece 
Good 
Hussey PS et al.11 The PROMETHEUS bundled payment 
experiment: slow start shows problems in 
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Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Kamath 
AF et al.8 
Yes Yes Yes Yes Yes Yes Yes Yes Yes 
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Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Delisle 
DR.10 
Yes No N/A N/A N/A N/A N/A N/A N/A 
Hussey 
PS et al.11 
Yes Yes Yes Yes Yes Yes Yes Yes Yes 











 Seven of the nine articles included in the systematic review were qualitative 
studies of some sort. The remaining two were considered to be commentaries or 
opinion pieces of some sort. Of the seven studies which were appraised using the 
CASP appraisal tool for qualitative research, only one of the studies did not earn an 
answer of “yes” to all of the questions; therefore, it received a rating of “fair”. The 
other five studies earned a “yes” to all of the questions posed by the CASP too, and, 
therefore, earned a rating of “good”. Finally, both of the articles which were classified 
as a commentary or opinion piece earned a rating of “good”.  
The study performed by Courtney et al.3 was deemed to be of good quality 
because it met all of the criteria posed by the CASP template. The researchers 
examined the difference in CMS episode of care cost, length of stay in the hospital, 
and readmission rate before and after the implementation of the CJR model at their 
institution. They did an adequate job of minimizing risk of selection bias by including 
all patients who underwent the procedure in successive calendar years and the 
patients appeared to have very similar demographical information. Due to the fact 
that the qualitative assessment was retrospective, there was no randomization, 
which means that there exists a risk for confounding between the two groups. Their 
results showed no difference in total episode-of-care cost to CMS, nor index 
hospitalization reimbursement. They did find a difference in the average length of 
stay (4.02 days for patients enrolled in the bundle vs. 5.27 days for non-bundled 
patients, p=0.001). They also did a risk stratification analysis to determine 
independent risk factors for “high-cost episodes”. The three risk factors that 
contributed the most were: Disposition to inpatient rehabilitation (odds ratio [OR], 




(OR, 3.66; 95% CI, 1.60–8.38; p = 0.002), and readmission within 90 days (OR, 
6.99; 95% CI, 2.58–18.91; p<0.001)3. They were also aware of some of the 
limitations of the study, and even discussed the possibility that the difference in 
length of stay may simply be due to the fact that there was education to the providers 
advocating for a reduced length of stay before implementation of the bundle. Finally, 
they did not discuss the systematic process and challenges associated with bundle 
implementation, only clinical data differences. 
Porter and Kaplan4 provided a commentary on the differences between fee-for 
service, capitation, and bundled payments. This piece was well-thought out, 
comprehensive, and useful. It made claims and backed them up with data. 
Therefore, it received a “good” rating. 
Randazzo and Brown5 penned an article describing Northwell Health 
Network’s experience with several bundled payments. This was a qualitative 
assessment of the various steps their system took to prepare for integration. They 
noted a 10% reduction in readmission rate, 4% decrease in absolute skilled nursing 
facility utilization, and a savings of $1,535 per case5. They discussed what worked, 
what challenges they experienced, and communicated it in a manner that is useful 
for other systems to take note of. 
Whitcomb et al.6 described the experience their institution, Baystate Health, 
had with implementing a total hip replacement bundle. They noted the patients who 
were bundled were more likely to be discharged directly home (87% vs. 63%, 
p=0.03)6. They also noticed a cheaper cost per case ($22,567 vs. $26,412, 
p=0.0001), although there was no difference after they adjusted for various factors. 
They felt that all of the cost savings came from lower utilization of SNIFs. They also 




and engaging stakeholders early were the most important contributors to 
implementation6. They did note some possible selection bias, mainly due to baseline 
differences in the patients, which led to the article receiving a rating of “fair”. 
Bencic et al.7 describes a qualitative assessment and description of two care 
redesign programs at two large academic medical centers, Duke University Health 
System and the University of Colorado Health System. Duke decided not to pursue a 
Congestive Heart Failure bundled payment because of the inherent variability in the 
disease. They also felt that it would’ve been incredibly difficult to define the episode 
of care or standardize the care in their patient population. Meanwhile, Colorado 
chose to implement a 30 day, model 4 bundle for CHF. This allowed them to set the 
stage to work toward a fixed budget with prospective payments. Both institutions 
noted that clinical leadership is essential. They also noted that having an outside 
institution to focus on providing technical assistance and implementation support 
was vital. These were both very small scale pilot programs in CHF care, however, so 
it is hard to draw conclusions from them. 
The study performed by Kamath et al.8 described a qualitative study in which 
they sent an electronic questionnaire to physicians who were members of the 
American Association of Hip and Knee Surgeons. They had a 25.3% response rate. 
They noted that 61% of respondents were planning to participate in an APM, and 
45% felt that bundled payments are the most effective method to increase quality 
and decrease costs. However, 94% felt bundled payments would discourage 
operating on high risk patients8. They were also cognizant of the possibility of bias 
from mixing data from respondents who are participating in an APM with those who 




A study by Chambers et al.9 examined the expanded end stage renal disease 
bundle. The majority of their analysis looked at some clinical questions, however, 
they also talked about some general insights for bundled payments. For example, 
they commented on the importance of stakeholder input and staged implementation. 
In addition, they mention that the future of bundled payments may be limited by their 
administrative complexity, but that this can be circumvented through collaboration 
and communication of successful strategies from other institutions. This study 
included all of the aspects of the CASP appraisal tool, so it was given a rating of 
“good”. 
The paper by Dennis Delisle10 in 2013 discusses the likely implications of 
mandatory bundled payment implementation. It talks about the shortcomings of the 
traditional fee-for-service system, then discusses the potential models that could 
exist, three retrospective bundled payment models, and one prospective bundled 
payment model. He finishes by revealing challenges of implementation. He adds that 
one of the most integral pieces is to have physician buy-in and leadership as early as 
possible. He also notes that significant financial incentive may be necessary for 
some physicians to buy-in. Finally, he discusses how vital risk stratification is to the 
success of a bundled payment program. This paper received a “good” rating 
because it avoided excessive subjective assertions and provided evidence to 
prevent baseless claims. 
Finally, the study by Hussey et al.11 (The PROMETHEUS experiment) in 2011 
was a qualitative assessment of the progress of three bundled payment pilot sites by 
interviewing key stakeholders. At the time of writing, none of the three sites had yet 
implemented a bundled payment, they felt largely due to the administrative 




payment amount was calculated. Next, they spoke about the challenges to 
implementation. They also reported that the largest difficulties lie in: defining the 
episode, engaging providers, accurately measuring outcomes, and determining 
accountability. They described their methods and attempted to avoid bias by 
ensuring anonymity to the respondents at each of the three pilot sites. It seemed that 
none of the sites created a separate entity to assist with data analytics, so they all 
three struggled immensely with deciding how to benchmark, determining a baseline, 
and understanding the language and terms PROMETHEUS was using11. However, 
the process allowed those involved to realize the value of this pursuit, as it helped 
open up lines of communication, identify gaps in measurement capabilities, and 
begin to develop care coordination services. The study contained all aspects of the 
CASP appraisal tool, so it received a rating of “good”. 
 
The combined articles seemed to answer the questions of the systematic 
review as follows: 
1.) How have health care systems in the United States handled the 
implementation of bundled payments? 
The articles included described a spectrum of experiences with their integration 
of bundled payments. Some experienced modest successes, while some 
experienced no difference. However, all of them described the challenge associated 
with undergoing the endeavor of implementing a bundled payment model. None of 






2.) What challenges have health care systems encountered in the 
implementation of bundled payments? 
Other health care systems seemed to struggle the most with measuring their 
performance. Many of them discussed how much work was put in before the 
implementation into developing the data analytic infrastructure necessary to 
successfully implement the bundled payment and be able to ascertain meaningful 
data from its integration. Some of them also described difficulty in defining the 
episode length. The article by Porter and Kaplan mentioned that this was a common 
barrier systems were encountering with implementation4. 
 
3.) What insights can health care systems offer to other health care 
systems who are attempting to implement bundled payments? 
The most important aspect of the process that the articles included seemed to 
endorse was the importance of constant feedback and communication. Another 
important insight was the utilization of care coordinators or care managers, who were 
a new role created, often a nurse practitioner which was mentioned by several of the 
articles. Most of the articles which described implementation of a bundled payment 
system also noted that they created a separate entity within their health care system 
to handle things such as data analytics, content expertise, stakeholder engagement, 
performance review, and accountability, such as “Care Solutions,” described in the 
article by Randazzo and Brown5. 
 
Discussion 
 The results of this systematic review seem to support the overall theme of 




situation, providers are willing to be involved, there is a team in place dedicated to 
the bundle’s success, and there is constant feedback and communication amongst 
those involved. The variety of experiences experienced by the health systems 
included in the study makes it difficult to come up with an overall conclusion of what 
can best be done to implement a bundled payment program.  
 The major limitation of this systematic review stems from the fact that the 
qualitative studies included retrospective analyses, so there was no opportunity for 
randomization of bundled vs. non-bundled patients; this leaves the possibility for 
confounding with all of the results. In addition, most of these studies had relatively 
small sample sizes, although this largely has to do with the fact that there are only so 
many complete joint replacements done in a year. 
 This limited systematic reviewed shed light on the experiences some health 
systems have had when implementing bundled payments. The results were 
equivocal, which is consistent with the results of the interviews with key stakeholders 
at UNC Health Care. As the CJR model and future CMS mandated bundled 
payments, such as the heart and vascular model, roll out it will be prudent to 
evaluate the experiences the health systems involved had. Interviews with key 
stakeholders involved in the implementation at as many of the involved institutions 
should occur in order to synthesize the most effective strategy for implementation 
moving forward. Finally, a large meta-analysis of all of these implementation 
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10 questions to help you make sense of 
qualitative research 
How to use this appraisal tool: 
  
Three broad issues need to be considered when appraising a qualitative study:  
  
Are the results of the study valid?  (Section A)  
What are the results?      (Section B)  
Will the results help locally?     (Section C)  
  
The 10 questions on the following pages are designed to help you think about these issues 
systematically. The first two questions are screening questions and can be answered 
quickly. If the answer to both is “yes”, it is worth proceeding with the remaining questions.  
  
There is some degree of overlap between the questions, you are asked to record a “yes”, 
“no” or “can’t tell” to most of the questions. A number of italicized prompts are given after 
each question. These are designed to remind you why the question is important. Record 
your reasons for your answers in the spaces provided.  
  
These checklists were designed to be used as educational pedagogic tools, as part of a 
workshop setting, therefore we do not suggest a scoring system. The core CASP checklists 
(randomized controlled trial & systematic review) were based on JAMA 'Users’ guides to 
the medical literature 1994 (adapted from Guyatt GH, Sackett DL, and Cook DJ), and 
piloted with health care practitioners.  
   
For each new checklist a group of experts were assembled to develop and pilot the 
checklist and the workshop format with which it would be used. Over the years, overall 
adjustments have been made to the format, but a recent survey of checklist users reiterated 
that the basic format continues to be useful and appropriate.  
  
Referencing: we recommend using the Harvard style citation, i.e.:  
  
Critical Appraisal Skills Programme (2017). CASP (insert name of checklist i.e. 
Qualitative Research) Checklist. [online] Available at:  URL. Accessed: Date 
Accessed.  
  
©CASP this work is licensed under the Creative Commons Attribution – Non Commercial-
Share A like. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-






Screening Questions  
1. Was there a clear statement of the aims of the research?    
   Yes Can’t tell No          
HINT: Consider  
• What was the goal of the 
research?  
• Why it was thought important?  





2. Is a qualitative methodology appropriate?                      
Yes  Can’t tell No  
  
HINT: Consider  
• If the research seeks to interpret 
or illuminate the actions and/or 
subjective experiences of 
research participants  
• Is qualitative research the right 
methodology for addressing the 





Is it worth continuing?                            
  
Detailed questions: 
3. Was the research design appropriate to address the aims of the 
research?  
       Yes Can’t tell  No       




• If the researcher has justified the 
research design (E.g. have they 
discussed how they decided 




4. Was the recruitment strategy appropriate to the aims of the 
research?  
    Yes  Can’t tell No       
HINT: Consider  
• If the researcher has explained 
how the participants were 
selected  
• If they explained why the 
participants they selected were 
the most appropriate to provide 
access to the type of knowledge 
sought by the study  
• If there are any discussions 
around recruitment (e.g. why 
some people chose not to take 
part)  
          
  
5. Was the data collected in a way that addressed the research 
issue?  
Yes  Can’t tell No      
  
 
HINT: Consider   
• If the setting for data collection 
was justified  
• If it is clear how data were 
collected (e.g. focus group, 
semi-structured interview etc.)  
• If the researcher has justified the 
methods chosen  
• If the researcher has made the 




interview method, is there an 
indication of how interviews 
were conducted, or did they use 
a topic guide)?  
• If methods were modified during 
the study. If so, has the 
researcher explained how and 
why?  
• If the form of data is clear (e.g. 
tape recordings, video material, 
notes etc.)  
• If the researcher has discussed 
saturation of data  
  
  
6. Has the relationship between researcher and participants been 
adequately considered?  
Yes  Can’t tell No                                      
  
HINT: Consider  
• If the researcher critically 
examined their own role, 
potential bias and influence 
during   
(a) Formulation of the research 
questions  
(b) Data collection, including 
sample recruitment and        
choice of location  
• How the researcher responded 
to events during the study and 
whether they considered the 
implications of any changes in 
the research design  
   
7. Have ethical issues been taken into consideration?      
Yes  Can’t tell No                
  
HINT: Consider  
• If there are sufficient details of 




to participants for the reader to 
assess whether ethical 
standards were maintained  
• If the researcher has discussed 
issues raised by the study (e.g. 
issues around informed consent 
or confidentiality or how they 
have handled the effects of the 
study on the participants during 
and after the study)  
• If approval has been sought 
from the ethics committee  
  
  
8. Was the data analysis sufficiently rigorous?         
Yes  Can’t tell No  
HINT: Consider   
• If there is an in-depth description 
of the analysis process  
• If thematic analysis is used. If 
so, is it clear how the 
categories/themes were derived 
from the data?  
• Whether the researcher explains 
how the data presented were 
selected from the original 
sample to demonstrate the 
analysis process  
• If sufficient data are presented to 
support the findings  
• To what extent contradictory 
data are taken into account  
• Whether the researcher critically 
examined their own role, 
potential bias and influence 
during analysis and selection of 
data for presentation  
9. Is there a clear statement of findings?                         
Yes  Can’t tell No  
HINT: Consider  




• If there is adequate discussion 
of the evidence both for and 
against the researchers’ 
arguments  
• If the researcher has discussed 
the credibility of their findings 
(e.g. triangulation, respondent 
validation, more than one 
analyst)  
• If the findings are discussed in 





10. How valuable is the research?                                       
HINT: Consider  
• If the researcher discusses the 
contribution the study makes to 
existing knowledge or 
understanding e.g.  do they 
consider the findings in relation 
to current practice or policy, or 
relevant research-based 
literature?  
• If they identify new areas where 
research is necessary  
• If the researchers have 
discussed whether or how the 
findings can be transferred to 
other populations or considered 





APPENDIX 2 – Interview Protocol 
 
My name is Ryan Bradley and I am a 4th year medical student here at UNC getting 
my Master’s of Public Health. I’m working with Dr. Sue Tolleson-Rinehart in the 
Department of Pediatrics and the MD-MPH program, and Mr. Jeffrey Fuller of UNC 
Health Care’s Enterprise Analytics and Data Sciences Organization. Dr. Ian 
Buchanan is the second reader on my master’s paper.   
 
As I mentioned in my email message to you, my master’s paper is an analysis of 
UNC Health Care’s experience with integrating Bundled Payments. I am asking to 
talk with you because of your expertise in the area, and the important perspectives 
you can provide. I have done my best to educate myself on the topic, but really need 
your expert views!  
 
Do you consent to my interviewing you? (indicate Respondent’s agreement).  
 
Is it okay if I record our interview?  
  
Is it okay if I identify you by name in my master’s paper? Using your name will help 
the validity of the analysis. If you want to remain anonymous, I will simply identify 
you as “a UNC Health Care leader” or some other general mention by title.  
 
I am happy to share my paper with you once it is finished! Please just let me know!   
 
My study has been reviewed by the UNC IRB [and has been determined (not to be 
human subjects research) or (exempt from further review) or (approved).     
 
Thank you again for your willingness to help! Do you have any questions before we 








1. As you know, I am here to talk to you about UNC Health Care’s experience with 
bundled payments. My literature review has shown that other institutions have 
experienced a variety of challenges with the integration of bundled payments. How 
would you characterize UNC Health Care’s experience with integrating bundled 
payments?  
  
2. What steps do you believe UNC took to best handle the integration of alternative 
payment models, particularly bundled payments?   
  
3. The integration of a payment system such as bundled payments requires buy-in 
from many key stakeholders. What do you think are the most effective steps 
that [insert interviewee’s field] can take to get that buy-in? How do you persuade 
those stakeholders to embrace the change, or at least be willing to give it a chance? 
Money always makes things go better, I know, but apart from money, what kind 
of resources would have made the implementation smoother?    
 
3. a.  And, speaking of money, how does funds flow change because of bundled 
payments?  
  
4. [if Respondent doesn’t mention this elsewhere] What is the most prominent barrier 
to the adoption of bundled payments, at UNC?  
 
 
4.a.  Do other alternative payment models have different barriers?  
 
5. What can other academic medical centers take away from UNC’s experience with 
bundled payments in their own process of integrating them?  
  
 
6. What role do you see bundled payments playing in the future of UNC Health 






7. Do you think that certain procedures or admissions are more amenable to bundled 
payments than others? And what about different settings?  I’m especially interested 
in how bundled payments can extend across inpatient and outpatient settings – for 
example, combining all the inpatient and home-based rehab services in total joint 
replacement.  
And do you envision the use of bundled payments for purely outpatient treatments?  
  
 
8. Do you think the implementation of bundled payments at UNC has led to an 
improvement in the quality of care provided to patients?  Why/How/Why not?  
  
 
9. Thank you very much for your time and your insight. Is there anything I haven’t 





Appendix 3 - List of Interviewees 
 
Jeffrey Fuller, MS, FACHE 
Executive Director of Analytical Solutions,  
Enterprise Analytics & Data Sciences, 
UNC Health Care System 
 
 
Carol Lewis, MBA 
Associate Director, Center for Health Innovation 
UNC Health Care and School of Medicine 
 
 
Jake Yount, MBA 
Director, Network Pricing & Expense Analysis, 
Blue Cross & Blue Shield of North Carolina 
 
 
Darren DeWalt, MD MPH 
Chief, Division of General Medicine and Clinical Epidemiology 
UNC School of Medicine 
 
 
Kevin Kelly, MD 
Interim Chair, Department of Pediatrics 
UNC Health Care System 
 
 
Alan Stiles, MD 
Senior Vice President – Network Development and Strategic Affiliations 
UNC Health Care System 
 
 
Matthew Mauro, MD, FACR, FSIR, FAHA 
Chairman, Department of Radiology 
CEO, University of North Carolina Faculty Physicians 





APPENDIX 4 - Example of Coding Document 
 
 
 
